AI Article Synopsis
- New technologies for treating brain aneurysms, like PED and FRED, are making a big difference in medical care.
- This study looked at different research to compare how safe and effective PED and FRED are for patients.
- Results showed that while both devices worked similarly, FRED had better outcomes, meaning patients with FRED had more chances of doing well after treatment.
Article Abstract
Background: Advancements in flow diversion technology have revolutionized the treatment of intracranial aneurysms. The pipeline embolization device (PED) and the flow redirection endoluminal device (FRED) have emerged as prominent tools in this field. This study aims to compare the safety and efficacy profiles of PED and FRED in the treatment of intracranial aneurysms.
Methods: Following the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) guidelines, a comprehensive literature search was conducted across PubMed, Web of Science, and Scopus databases. Studies comparing PED and FRED were included and data extraction focused on study characteristics, patient demographics, and clinical and radiological outcomes. Primary outcomes were favorable outcomes, described as modified Rankin scale (mRS) 0-2 score, and complete/near-complete occlusion, while secondary outcomes included retreatment rate and thromboembolic and hemorrhagic complications.
Results: Five studies, comprising 1238 patients, were included. No significant differences were found between PED and FRED in terms of complete occlusion at 6 months and 1 year, complete/near-complete occlusion at the last follow up, retreatment rates, and thromboembolic, in-stent thrombosis and hemorrhagic complications. However, FRED was significantly associated with higher favorable outcomes compared to PED (odds ratio: 0.37; confidence interval: 0.17 to 0.81; p = 0.01).
Conclusion: This study showed that both PED and FRED had comparable rates of complete occlusion, retreatment and complications, and FRED also demonstrated a higher likelihood of achieving favorable outcomes. The study underscores the need for further research with larger cohorts and longer follow up to consolidate these findings.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11569761 | PMC |
| http://dx.doi.org/10.1177/15910199241264345 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Comparative analysis of safety and efficacy of flow diversion with and without surface modification technology, FRED-X, FRED, PED shield and PED in 386 patients: A single center experience with systematic review and network meta analysis.
J Neurol Sci
December 2024
Department of Neurological Surgery, Thomas Jefferson University Hospital, Philadelphia, PA, USA. Electronic address:
Introduction: The FRED-X is a newer generation flow diverting stent (FDS) with surface modification that has demonstrated favorable efficacy in treating intracranial aneurysms. Our study provides an analysis of patients treated using FRED-X compared to FRED, PED Shield and PED.
Materials And Methods: This was a retrospective single center study and a systematic review with network meta analysis of patients who underwent flow diversion using FRED-X, FRED, PED Shield or PED.
Flow diversion of cerebral aneurysms in Type I osteogenesis imperfecta: A case report of the first two treatments in humans.
SAGE Open Med Case Rep
August 2024
Carondelet Neurological Institute, St. Joseph's Hospital, Tucson, AZ, USA.
Article Synopsis
- Osteogenesis imperfecta (OI) is a genetic disorder that makes bones fragile and can lead to easy fractures, alongside issues with blood vessels and platelets.
- This case highlights the first successful use of a flow diversion technique for treating brain aneurysms in a 62-year-old female patient with OI Type I, who had a long history of fractures and was being treated for transient ischemic attacks.
- After successfully treating two aneurysms with devices, the patient showed complete obliteration of both, remained asymptomatic, and had no complications during the five years of follow-up.
Comparison of pipeline embolization device and flow redirection endoluminal device in the treatment of intracranial aneurysms: A systematic review and meta-analysis.
Interv Neuroradiol
July 2024
Department of Neurosurgery, Duke University Hospital, Durham, NC, USA.
Article Synopsis
- New technologies for treating brain aneurysms, like PED and FRED, are making a big difference in medical care.
- This study looked at different research to compare how safe and effective PED and FRED are for patients.
- Results showed that while both devices worked similarly, FRED had better outcomes, meaning patients with FRED had more chances of doing well after treatment.
Comparative Efficacy of Flow Diverter Devices in the Treatment of Carotid Sidewall Intracranial Aneurysms: a Retrospective, Multicenter Study.
Clin Neuroradiol
December 2024
Department of Neurosurgery and Interventional Neuroradiology, Louisiana State University, Baton Rouge, LA, USA.
Article Synopsis
- - The study compared the effectiveness and safety of four first-generation flow diverters (FDs) used for treating sidewall ICA intracranial aneurysms, which include Pipeline, Silk, FRED, and Surpass devices, using data from 444 patients across 18 institutions from 2009-2016.
- - Analysis revealed no significant differences in retreatment rates or complications among the devices; however, the Surpass device showed the highest probability of achieving effective occlusion at follow-up, followed by FRED, Pipeline, and Silk.
- - Although all devices had good clinical outcomes, the study highlights the need for prospective research to further clarify the differences and long-term effects of these flow diverters.
Pipeline Embolization Device and Flow Re-Direction Endoluminal Device for Intracranial Aneurysms: A Comparative Systematic Review and Meta-Analysis Study.
World Neurosurg
September 2024
Department of Neurosurgery, Medical College of Georgia, Augusta University, Augusta, Georgia, USA. Electronic address:
Article Synopsis
- - The review compares two endovascular flow diversion methods for treating intracranial aneurysms: the Flow Re-Direction Endoluminal Device (FRED) and the Pipeline Embolization Device (PED), using data from various databases until October 8, 2023.
- - An analysis of 1,769 patients revealed similar occlusion rates at 6 months and 1 year for both devices, but FRED patients had better functional outcomes and lower rates of complications compared to PED.
- - The findings highlight that while FRED and PED are similarly effective, FRED is associated with fewer hemorrhages and re-treatments, making it important for clinicians to consider these differences when choosing treatment options.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!